All In Biotech

Drug Trial Radar · NCT06900920

A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia (ITP)

Last checked: Nov 19, 2026Latest source record: May 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 199 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

199

Planned (sponsor's estimate)

Start

Apr 30, 2025

Primary completion

Mar 2027

Study completion Dec 2027

Sponsor

Sponsor type
Industry
First posted
Mar 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled Phase III clinical study designed to demonstrate that TQB3473 tablets significantly improve the sustained response rate compared to placebo in adult patients with chronic ITP who have previously received standard corticosteroid therapy and have failed or relapsed after at least one standard ITP treatment. The study consists of a treatment period and a safety follow-up period.

Conditions

  • Primary Immune Thrombocytopenia

Interventions

  • TQB3473 TabletsDrug

    TQB3473 tablet is a selective Spleen tyrosine kinase (Syk) inhibitor.

  • TQB3473 PlaceboDrug

    Placebo contains no active substance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Durable response rate: platelet counts ≥50×10^9/LTime frame: During the 24-week randomized double-blind treatment period (Weeks 14-24)

Locations

53 sites in 1 country. Site status is shown where the registry gives one.

  • The first affiliated hospital of ustc anhui provincial hospital

    Hefei, Anhui, China · Not yet recruiting

  • The First Affiliated Hospital of Wannan Medical College

    Wuhu, Anhui, China · Not yet recruiting

  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, China · Not yet recruiting

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Shenzhen Nanshan People's Hospital

    Shenzhen, Guangdong, China · Not yet recruiting

  • Central People's Hospital of Zhanjiang

    Zhanjiang, Guangdong, China · Not yet recruiting

  • The Second Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Not yet recruiting

  • The Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China · Not yet recruiting

  • The First Affiliated Hospital of Hainan Medical University

    Haikou, Hainan, China · Not yet recruiting

  • Affiliated Hospital of Hebei University / School of Clinical Medicine

    Baoding, Hebei, China · Recruiting

  • Affiliated Hospital of ChengDe Medical University

    Chengde, Hebei, China · Not yet recruiting

  • The First Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Not yet recruiting

  • North China University of science and technology

    Tangshan, Hebei, China · Not yet recruiting

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Not yet recruiting

  • Anyang People's Hospital

    Anyang, Henan, China · Not yet recruiting

  • Nanyang Central Hospital

    Nanyang, Henan, China · Not yet recruiting

  • Xuchang Central Hospital

    Xuchang, Henan, China · Not yet recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Not yet recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • The First People's Hospital of Ping Ding Shan

    Zhengzhou, Henan, China · Not yet recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China · Not yet recruiting

  • The Third Hospital of Changsha

    Changsha, Hunan, China · Not yet recruiting

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, China · Not yet recruiting

  • Northern Jiangsu People's Hospital Affiliated to Yangzhou University

    Yangzhou, Jiangsu, China · Not yet recruiting

  • Ganzhou People's Hospital

    Ganzhou, Jiangxi, China · Not yet recruiting

  • The First Affiliated Hospital of NanChang University

    Nanchang, Jiangxi, China · Not yet recruiting

  • The first hospital of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • Shenjing Hospital Of China Medical University

    Shenyang, Liaoning, China · Not yet recruiting

  • Qinghai University Affiliated Hospital

    Xining, Qinghai, China · Not yet recruiting

  • Xijing Hospital

    Xi'an, Shaanxi, China · Not yet recruiting

  • Xi'an No.3 Hospital

    Xi'an, Shaanxi, China · Not yet recruiting

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China · Not yet recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • Shandong First Medical University Affiliated Central Hospital

    Jinan, Shandong, China · Not yet recruiting

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.